These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20576639)

  • 1. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species.
    Kawamura-Sato K; Wachino J; Kondo T; Ito H; Arakawa Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1975-83. PubMed ID: 20576639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material.
    Kawamura-Sato K; Wachino J; Kondo T; Ito H; Arakawa Y
    J Antimicrob Chemother; 2008 Mar; 61(3):568-76. PubMed ID: 18192683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in chlorhexidine efficacy against multi-drug-resistant Acinetobacter baumannii international clone II.
    Hayashi M; Kawamura K; Matsui M; Suzuki M; Suzuki S; Shibayama K; Arakawa Y
    J Hosp Infect; 2017 Mar; 95(3):318-323. PubMed ID: 28159381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
    J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
    Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
    J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong].
    García-Peñuela E; Aznar E; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2006 Mar; 19(1):45-50. PubMed ID: 16688291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
    Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
    Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanism of multiple-drug and pan-drug resistance among Acinetobacter species].
    Wang H; Sun HL; Ning YZ; Yang QW; Chen MJ; Zhu YJ; Xu YC; Xie XL
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):17-22. PubMed ID: 16606529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification and sensitivity of acinetobacter sp isolated from clinical specimens and hospital environment].
    Martínez MA; Pinto ME; Giglio MS; Pommier J; Muñoz LM
    Rev Med Chil; 1992 Nov; 120(11):1267-72. PubMed ID: 1340947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.
    Wisplinghoff H; Schmitt R; Wöhrmann A; Stefanik D; Seifert H
    J Hosp Infect; 2007 Jun; 66(2):174-81. PubMed ID: 17498843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of different bacterial species isolated from food animals to copper sulphate, zinc chloride and antimicrobial substances used for disinfection.
    Aarestrup FM; Hasman H
    Vet Microbiol; 2004 May; 100(1-2):83-9. PubMed ID: 15135516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.